EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report

Steven B Barker, Adeoluwa Adewuyi

Cureus · 14.05.2025

DOI: 10.7759/cureus.84121 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 14.05.2025. Verfasst von Steven B Barker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Northeast Georgia Medical Center Gainesville, Gainesville, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adenocarcinoma-gastric typeimmune checkpoint inhibitorsimmune therapy-mediated myocarditisimmune therapy-mediated myositisimmune-related adverse event (irae)ipilimumab-related adverse eventsnivolumab-related adverse events

Autor:innen und Institutionen

  • Internal Medicine, Northeast Georgia Medical Center Gainesville, Gainesville, USA.

Zitieren

APA

Barker, S. B., & Adewuyi, A. (2025). Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report. Cureus. https://doi.org/10.7759/cureus.84121

Vancouver

Barker SB, Adewuyi A. Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report. Cureus. 2025. doi:10.7759/cureus.84121

BibTeX
@article{Barker2025,
  author = {Barker, Steven B and Adewuyi, Adeoluwa},
  title = {Rapid-Onset Myositis and Myocarditis Following Dual Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Gastric Adenocarcinoma: A Case Report},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.84121}
}
Kostenlos starten →